Bridgewater, NJ, United States of America

Ezra R Lowe

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bausch Health Ireland Limited. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ezra R. Lowe

Introduction

Ezra R. Lowe is an accomplished inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the targeted delivery of medications. Her innovative work has the potential to improve treatment outcomes for patients with gastrointestinal disorders.

Latest Patents

Ezra R. Lowe holds a patent for "Targeted release rifaximin compositions." This patent describes gastrointestinal-specific rifaximin release compositions that can be formulated for targeted delivery to various portions of the GI tract. The patent also outlines methods for treating diseases and disorders using these compositions, showcasing her commitment to advancing medical treatments.

Career Highlights

Ezra is currently employed at Bausch Health Ireland Limited, where she continues to develop innovative solutions in the pharmaceutical industry. Her work at Bausch Health highlights her dedication to improving patient care through scientific advancements.

Collaborations

Ezra has collaborated with notable colleagues, including Daniel J. Stein and Brian R. Rohrs. These partnerships reflect her ability to work effectively within a team to drive innovation and achieve common goals.

Conclusion

Ezra R. Lowe's contributions to the field of pharmaceuticals, particularly through her patent on targeted rifaximin compositions, demonstrate her innovative spirit and commitment to enhancing healthcare solutions. Her work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…